The drug is touted as a game-changer in the fight against the pandemic, and a panel of experts of the US Food and Drug Administration (FDA)...

Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...

Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...

The firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...

In a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceu...

Earlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.

In a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...

Developed by DRDO, 2-DG has been granted permission by the Drug Controller General of India (DCGI) for emergency use as adjunct therapy in ...

The company said it has received its clinical trial approval on May 19, 2021, from the Drug Controller General of India (DCGI) to perform a...

MSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Osel...

The company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...

As part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow ...

In India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.

MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few month...

MSN Laboratories Limited, will foray into the pain management market with the launch of 'Tapentadol' a pain killer under brand name Tapal i...

Senior professionals have earned enough expertise to start their own ventures at a time when the market and funding options are favourable.

Professionals in pharma and biotechnology companies are increasingly taking the plunge to set up start-ups - a trend which investors descri...